vs
Side-by-side financial comparison of Citi Trends Inc (CTRN) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.
Citi Trends Inc is the larger business by last-quarter revenue ($197.1M vs $151.7M, roughly 1.3× Nutex Health, Inc.). Nutex Health, Inc. runs the higher net margin — 7.8% vs -3.5%, a 11.3% gap on every dollar of revenue. On growth, Citi Trends Inc posted the faster year-over-year revenue change (10.1% vs -41.1%). Nutex Health, Inc. produced more free cash flow last quarter ($69.0M vs $767.0K). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs -4.3%).
Citi Trends, Inc. is an American retail clothing chain selling discounted products targeted primarily at African-American customers.
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
CTRN vs NUTX — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $197.1M | $151.7M |
| Net Profit | $-6.9M | $11.8M |
| Gross Margin | — | 30.4% |
| Operating Margin | -3.7% | 20.4% |
| Net Margin | -3.5% | 7.8% |
| Revenue YoY | 10.1% | -41.1% |
| Net Profit YoY | 3.6% | -80.8% |
| EPS (diluted) | $-0.86 | $2.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $197.1M | $151.7M | ||
| Q3 25 | $190.8M | $267.8M | ||
| Q2 25 | $201.7M | $244.0M | ||
| Q1 25 | $211.2M | $211.8M | ||
| Q4 24 | $179.1M | $257.6M | ||
| Q3 24 | $176.6M | $78.8M | ||
| Q2 24 | $186.3M | $76.1M | ||
| Q1 24 | $215.2M | $67.5M |
| Q4 25 | $-6.9M | $11.8M | ||
| Q3 25 | $3.8M | $55.4M | ||
| Q2 25 | $871.0K | $-17.7M | ||
| Q1 25 | $-14.2M | $21.2M | ||
| Q4 24 | $-7.2M | $61.6M | ||
| Q3 24 | $-18.4M | $-8.8M | ||
| Q2 24 | $-3.4M | $-364.0K | ||
| Q1 24 | $3.6M | $-364.0K |
| Q4 25 | — | 30.4% | ||
| Q3 25 | — | 57.8% | ||
| Q2 25 | — | 51.2% | ||
| Q1 25 | — | 55.9% | ||
| Q4 24 | — | 55.0% | ||
| Q3 24 | — | 27.8% | ||
| Q2 24 | — | 29.7% | ||
| Q1 24 | — | 15.1% |
| Q4 25 | -3.7% | 20.4% | ||
| Q3 25 | 1.8% | 48.7% | ||
| Q2 25 | 0.2% | 13.8% | ||
| Q1 25 | 0.6% | 38.1% | ||
| Q4 24 | -4.9% | 44.4% | ||
| Q3 24 | -14.1% | 12.3% | ||
| Q2 24 | -3.7% | 7.0% | ||
| Q1 24 | 1.8% | 2.1% |
| Q4 25 | -3.5% | 7.8% | ||
| Q3 25 | 2.0% | 20.7% | ||
| Q2 25 | 0.4% | -7.3% | ||
| Q1 25 | -6.7% | 10.0% | ||
| Q4 24 | -4.0% | 23.9% | ||
| Q3 24 | -10.4% | -11.2% | ||
| Q2 24 | -1.8% | -0.5% | ||
| Q1 24 | 1.7% | -0.5% |
| Q4 25 | $-0.86 | $2.34 | ||
| Q3 25 | $0.46 | $7.76 | ||
| Q2 25 | $0.11 | $-2.95 | ||
| Q1 25 | $-1.70 | $3.33 | ||
| Q4 24 | $-0.86 | $11.56 | ||
| Q3 24 | $-2.21 | $-1.72 | ||
| Q2 24 | $-0.42 | $-0.07 | ||
| Q1 24 | $0.43 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $185.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $107.8M | $329.4M |
| Total Assets | $464.3M | $918.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $185.6M | ||
| Q3 25 | — | $166.0M | ||
| Q2 25 | — | $96.7M | ||
| Q1 25 | — | $84.7M | ||
| Q4 24 | — | $40.6M | ||
| Q3 24 | — | $46.9M | ||
| Q2 24 | — | $40.8M | ||
| Q1 24 | — | $30.0M |
| Q4 25 | $107.8M | $329.4M | ||
| Q3 25 | $113.2M | $317.2M | ||
| Q2 25 | $108.6M | $235.3M | ||
| Q1 25 | $113.2M | $176.9M | ||
| Q4 24 | $130.3M | $132.4M | ||
| Q3 24 | $136.6M | $60.4M | ||
| Q2 24 | $154.8M | $62.7M | ||
| Q1 24 | $157.7M | $63.0M |
| Q4 25 | $464.3M | $918.5M | ||
| Q3 25 | $457.4M | $964.5M | ||
| Q2 25 | $437.4M | $841.0M | ||
| Q1 25 | $462.8M | $761.9M | ||
| Q4 24 | $467.1M | $655.3M | ||
| Q3 24 | $506.7M | $438.5M | ||
| Q2 24 | $484.1M | $422.4M | ||
| Q1 24 | $518.7M | $404.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.6M | $70.4M |
| Free Cash FlowOCF − Capex | $767.0K | $69.0M |
| FCF MarginFCF / Revenue | 0.4% | 45.5% |
| Capex IntensityCapex / Revenue | 4.0% | 0.9% |
| Cash ConversionOCF / Net Profit | — | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | $11.9M | $245.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.6M | $70.4M | ||
| Q3 25 | $3.9M | $99.5M | ||
| Q2 25 | $-11.0M | $27.3M | ||
| Q1 25 | $28.5M | $51.0M | ||
| Q4 24 | $-18.4M | $54.0K | ||
| Q3 24 | $5.6M | $6.8M | ||
| Q2 24 | $-19.6M | $13.3M | ||
| Q1 24 | $23.3M | $3.1M |
| Q4 25 | $767.0K | $69.0M | ||
| Q3 25 | $-1.7M | $99.2M | ||
| Q2 25 | $-13.1M | $26.5M | ||
| Q1 25 | $26.0M | $50.9M | ||
| Q4 24 | $-20.4M | $-341.0K | ||
| Q3 24 | $1.7M | $6.2M | ||
| Q2 24 | $-21.2M | $12.7M | ||
| Q1 24 | $20.0M | $2.3M |
| Q4 25 | 0.4% | 45.5% | ||
| Q3 25 | -0.9% | 37.0% | ||
| Q2 25 | -6.5% | 10.9% | ||
| Q1 25 | 12.3% | 24.0% | ||
| Q4 24 | -11.4% | -0.1% | ||
| Q3 24 | 0.9% | 7.8% | ||
| Q2 24 | -11.4% | 16.7% | ||
| Q1 24 | 9.3% | 3.4% |
| Q4 25 | 4.0% | 0.9% | ||
| Q3 25 | 2.9% | 0.1% | ||
| Q2 25 | 1.0% | 0.3% | ||
| Q1 25 | 1.2% | 0.0% | ||
| Q4 24 | 1.1% | 0.2% | ||
| Q3 24 | 2.2% | 0.8% | ||
| Q2 24 | 0.9% | 0.7% | ||
| Q1 24 | 1.5% | 1.1% |
| Q4 25 | — | 5.95× | ||
| Q3 25 | 1.01× | 1.80× | ||
| Q2 25 | -12.59× | — | ||
| Q1 25 | — | 2.40× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 6.56× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTRN
Segment breakdown not available.
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
